friendly reminder LPCN to submit NDA to FDA anytime Q2, 2019.. http://ir.lipocine.com/2019-03-27-Lipocine-Announces-ABPM-Labeling-Study-Results-Consistent-with-Recently-Approved-Testosterone-Replacement-Therapy